Chengdu, Sichuan
A postdoctoral researcher currently working at the Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University. His research primarily focuses on the mechanisms of resistance to radiotherapy, targeted therapy, and immunotherapy in lung cancer, head and neck tumors, and urothelial carcinoma. He has authored and co-authored 15 SCI articles published in journals such as Cancer Medicine, Cancers, and Frontiers in Immunology.
Dr. Lis research has been presented at prestigious conferences, including poster presentations at ASCO, WCLC, and ESMO. He serves as a reviewer for journals like Immunotherapy, Frontiers in Bioscience-Land, and Frontiers in Oncology. Additionally, he has participated as a Sub-Investigator in several Phase II clinical trials for innovative drugs conducted within the hospital.
He has led projects funded by the Sichuan Provincial Natural Science Foundation and the National Postdoctoral Research Fellowship Program. Dr. Li has also been involved in multiple national and provincial-level research projects.
Disclosures:
Monday, September 30, 2024
5:00 PM – 6:00 PM ET